The Efficacy Study of Neoadjuvant Xelox in Patients with Locally Advanced Lower Rectal Cancer

Trial Profile

The Efficacy Study of Neoadjuvant Xelox in Patients with Locally Advanced Lower Rectal Cancer

Completed
Phase of Trial: Phase II

Latest Information Update: 15 Oct 2016

At a glance

  • Drugs Capecitabine (Primary) ; Oxaliplatin (Primary)
  • Indications Rectal cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 Feb 2016 Status changed from active, no longer recruiting to completed, as per the published in the Anticancer Research.
    • 01 Feb 2016 Results published in the Anticancer Research
    • 02 Feb 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top